BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25637160)

  • 1. Effect of Dahuang zhechong formula on liver fibrosis in patients with chronic hepatitis B: a meta-analysis.
    Wei F; Lang Y; Gong D; Fan Y
    Complement Ther Med; 2015 Feb; 23(1):129-38. PubMed ID: 25637160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study on effect of dahuang zhechong wan combined with adefovir dipivoxil in preventing hepatic fibrosis in patients with chronic hepatitis B].
    Zhang L; Chang Y
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(6):862-4. PubMed ID: 22715739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical observation of the effect of Xuesaitong soft capsule on post-hepatitis fibrosis.
    Deng YQ; Fan XF; Li YD
    Chin J Integr Med; 2005 Mar; 11(1):11-4. PubMed ID: 15975300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis.
    Zhang T; Yang Y; Wang B; Zheng X; Wang L; Feng X; Li G; Shi J; Cao N
    Medicine (Baltimore); 2019 Dec; 98(51):e18458. PubMed ID: 31861022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meritorious integrated medical regimen for hepatic fibrosis and its complications
    Ye Z; Huang Q; She Y; Hu Y; Wu M; Qin K; Li L; Zhang C; Zuo X; Wei A; Mao D; Ye Q
    Front Med (Lausanne); 2022; 9():920062. PubMed ID: 36314011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
    Li H
    J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside analogs assisted with Chinese compound prescription in treating hepatic fibrosis of chronic hepatitis B patients: A protocol of systematic review and meta-analysis.
    Cheng M; Feng X; Wang L; Yang Y; Ma L; Wang B
    Medicine (Baltimore); 2020 Jul; 99(27):e21032. PubMed ID: 32629728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy].
    Tian YL; Zhu XY; Yin WW; Zang ZD; Wang L; Fu XL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):514-8. PubMed ID: 24074710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of antiviral nucleotide/nucleoside analogues and interferon on hepatitis B virus-related liver cirrhosis: a meta-analysis].
    Chen YS; Yi W; Jiang K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):811-6. PubMed ID: 23206298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meta-analysis on indirect comparison of Fuzheng Huayu Jiaonang and Anluo Huaxian Wan in treatment of chronic hepatitis B with liver fibrosis].
    Wang J; Peng FC
    Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(7):1492-1500. PubMed ID: 29728042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule].
    Chen H; Weng L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr; 20(4):255-7. PubMed ID: 11789260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of the clinical efficacy of live bifidobacterium bacteria preparation combined with entecavir in the treatment of hepatitis B virus-related cirrhosis].
    Chen H; Yuan HX; Li XH
    Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):258-264. PubMed ID: 37137851
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the Ganning formula on liver fibrosis in patients with chronic hepatitis B.
    Deng X; Liang J; Wu FS; Li YB; Tang YF
    J Tradit Chin Med; 2011 Dec; 31(4):282-7. PubMed ID: 22462232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meta-analysis of efficacy and safety of Liuwei Wuling Tablets combined with conventional drugs in treatment of liver fibrosis and cirrhosis in chronic hepatitis B].
    Hou MT; Ding KX; He TT; Yang Y; Bai ZF; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):224-234. PubMed ID: 35178929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of hepatocellular function influenced by Chinese drug Dahuang Zhechong pill].
    Cheng MH; Pan ZH; Rao GH; Xu JH; Zhang F; Chen WZ; Mo CJ
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):564-6. PubMed ID: 18536385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
    Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
    J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound Biejia-Ruangan tablet as an adjunctive therapy to entecavir for chronic hepatitis B complicated with hepatic fibrosis: A systematic review and meta-analysis of randomized controlled trials.
    Xu YH; Xue C
    Medicine (Baltimore); 2022 Aug; 101(32):e30020. PubMed ID: 35960113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.